Actualités Emmaus Life Sciences Inc - EMMA | Actions NASDAQ

Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

NEW YORK, March 30, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the...

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its...

Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum March 26th

TORRANCE, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB:EMMA), a leader in...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Amended Statement of Beneficial Ownership (3/a)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Quarterly Report (10-q)

i UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...

Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing

Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing -- Company Committed to Listing on Major Exchange -- PR...

Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis

Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis Related patents granted in...

Emmaus Life Sciences Adds Oncology Supply as Distributor

Emmaus Life Sciences Adds Oncology Supply as Distributor PR Newswire TORRANCE, Calif., Aug. 28, 2019 TORRANCE, Calif., Aug. 28, 2019 /PRNewswire/...

Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida

Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida Campaign spokesperson...

Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results

Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results -- Net Revenues Increase 128% Year-Over-Year, as FDA-Approved...

Emmaus Life Sciences Reiterates Financial Benefits from Recent Merger

Emmaus Life Sciences Reiterates Financial Benefits from Recent Merger -- Company to Announce Second Quarter Financial Results Next Week -- PR...

Emmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt Service

Emmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt Service -- Company to...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Emmaus Life Sciences Inc (EMMA)

Outils de qualité professionnelle, pour des investisseurs individuels.

EMMA Actualités

Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum March 26th

Current Report Filing (8-k)

Current Report Filing (8-k)

Amended Statement of Beneficial Ownership (3/a)

Quarterly Report (10-q)

Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing

Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis

Emmaus Life Sciences Adds Oncology Supply as Distributor

Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida

Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results

Emmaus Life Sciences Reiterates Financial Benefits from Recent Merger

Emmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt Service

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Emmaus Life Sciences Inc (EMMA) Actualités

Emmaus Life Sciences Inc (EMMA)

Outils de qualité professionnelle, pour des investisseurs individuels.

EMMA Actualités

Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum March 26th

Current Report Filing (8-k)

Current Report Filing (8-k)

Amended Statement of Beneficial Ownership (3/a)

Quarterly Report (10-q)

Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing

Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis

Emmaus Life Sciences Adds Oncology Supply as Distributor

Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida

Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results

Emmaus Life Sciences Reiterates Financial Benefits from Recent Merger

Emmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt Service

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités